0001085037-18-000013.txt : 20180124 0001085037-18-000013.hdr.sgml : 20180124 20180124164558 ACCESSION NUMBER: 0001085037-18-000013 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180124 DATE AS OF CHANGE: 20180124 EFFECTIVENESS DATE: 20180124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TheraPten Biosciences Inc. CENTRAL INDEX KEY: 0001728964 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-304009 FILM NUMBER: 18545773 BUSINESS ADDRESS: STREET 1: 101 -1865 DILWORTH DRIVE STREET 2: #702 CITY: KELOWNA STATE: A1 ZIP: V1Y 9T1 BUSINESS PHONE: 250-864-2740 MAIL ADDRESS: STREET 1: 101 -1865 DILWORTH DRIVE STREET 2: #702 CITY: KELOWNA STATE: A1 ZIP: V1Y 9T1 D 1 primary_doc.xml X0708 D LIVE 0001728964 TheraPten Biosciences Inc. 101 -1865 DILWORTH DRIVE #702 KELOWNA A1 BRITISH COLUMBIA, CANADA V1Y 9T1 250-864-2740 BRITISH COLUMBIA, CANADA None None Corporation true 2016 Athanasios Alevizopoulos Chemin du Vallon 4 Yverdon-les-Bains V8 SWITZERLAND 1400 Executive Officer Director Chief Executive Officer Harvey Lalach 4257 Gallaghers Fairway S. Kelowna A1 BRITISH COLUMBIA, CANADA V1W 4X4 Executive Officer Director Chief Business Officer Kyriakoulis Paganis Solomou 39 #26 Anavyssos J3 GREECE 19013 Director Yiannis Monovoukas 11 Dellbrook Road Weston MA MASSACHUSETTS 02493 Director Biotechnology Not Applicable 06b false 2018-01-04 false true true true false 0 500000 500000 0 false 1 0 0 0 false TheraPten Biosciences Inc. /s/ Harvey Lalach Harvey Lalach Director 2018-01-24